Skip to search formSkip to main contentSkip to account menu

PF-00610355

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Background and ObjectivesPF-00610355 is an orally inhaled long-acting β2-adrenoreceptor agonist that is being developed for the… 
2013
2013
AIM To assess the cardiovascular effects of a new inhaled long-acting β-adrenoceptor agonist PF-00610355 in COPD patients… 
2012
2012
The objective of this work was to characterize the dose–response relationship between two inhaled long-acting beta agonists (PF… 
Review
2010
Review
2010
Purpose of review Because of the central role of bronchodilators in the treatment of asthma, in recent years there has been a…